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Contribution of mononuclear leucocytes to the progression of
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Contribution of mononuclear leucocytes to the progression of experi-
mental focal glomerular sclerosis. Uninephrectomized Sprague-Dawley
rats repeatedly administered with aminonucleoside of puromycin and
protamine sulfate developed progressive focal glomerular sclerosis
(FGS). The contribution to disease progression of both glomerular and
interstitial infiltrating leucocytes was studied throughout the disease
evolution. Leucocyte subsets were quantitated with an immunoper-
oxidase technique using monoclonal antibodies for rat leucocyte sur-
face antigens: OXI (total leucocytes) 0X6 (Ia positive cells), 0X8
(suppressor/cytotoxic T cells), 0X19 (total T cells), 0X22 (B cells and
subsets of T cells), and EDI (macrophages/monocytes). In the glomer-
uli, macrophages and Ia positive cells were significantly increased when
sclerotic lesions appeared, but T lymphocytes and subsets of T lym-
phocytes were not found. However, in the interstitium, all leucocytes
were identified and increased in number throughout the disease evolu-
tion. Early in the disease, monocytes and lymphocytes were both
present in large numbers, but at the end stage of the process, the
predominant infiltrating leucocytes were CD4 T cells. In FGS rats
treated throughout the disease with oral prednisolone (begun after
disease induction), renal function was significantly better than in the
untreated group, whereas the sclerosis and leucocyte accumulation in
the glomeruli were unchanged. However, prednisolone treatment re-
sulted in significantly fewer interstitial leucocytes and especially re-
duced the numbers of CD4+'e cells. These results suggest that the
glomerular sclerotic lesions are related to the participation of macro-
phages independent of T cells, and that immune mechanisms mediated
by T cells in the interstitium have an important role in the progression
of this disease to end-stage renal failure. Such findings could infer that
disease progression in glomerulonephritis, whether initiated by immune
mechanisms or not, may be related to an interstitial immune inflamma-
tory process mediated by lymphocytes and macrophages.
Focal glomerular sclerosis (FGS) can be experimentally
induced by non-immunological procedures, for example, ad-
ministration of aminonucleoside [1—31, ablation of kidneys [4,
51, protein [61 or cholesterol [7, 8] supplementation. In such
models, however, the contribution of cellular immune mecha-
nisms has been suspected because of the interstitial leucocytic
infiltration, although neither the participation of the immune
response in the development of glomerular sclerotic changes
nor the progression to renal failure have been assessed. There-
fore, we examined the distribution of leucocytes including
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monocytes and T-lymphocytes and their subsets, within the
glomeruli and the interstitium, in a progressive FGS model in
rats which mimics the human disease [3], using monoclonal
antibodies as markers of leucocyte subpopulations. The effect
of prednisolone treatment after disease induction was assessed
and the functional, histological and leucocytic changes, corre-
lated.
Methods
Experimental design
Experiment 1. The experimental model was recently reported
[3]. In brief, fifteen uninephrectomized 10 to 12 week old male
rats of Sprague-Dawley (SD) strain were given aminonucleoside
of puromycin (AN) and protamine sulfate (PS) for four days.
AN and PS were daily injected, subcutaneously in a dose of 1
mg per 100 g body weight and intravenously in two doses of 2.5
mg per 100 g body weight, respectively. Rats received further
four day series of injections at 10 day intervals in which the AN
dose was reduced to 0.5 mg per 100 g body weight. Each five
rats were sacrificed on day 24 after two series of injections, and
day 52 and 80 after four series. Five rats received saline alone
at the same volume of solution and were sacrificed on day 80.
Experiment 2. Fourteen uninephrectomized SD rats received
two series of injections AN and PS according to the same
protocol of experiment 1. From day 30, 12 days after the second
series of injections, seven rats were treated orally for 50 days
with prednisolone in tap water at a dose of 3 mg per kg body
weight. Dosage was adjusted by daily intake of tap water and
concentration of prednisolone. Seven control rats were not
treated by steroid. Fourteen rats were injected with two series
of saline, and subsequently half of them were treated with
prednisolone as described above. All rats were sacrificed on
day 80.
Histology
Portions of kidney were fixed in 10% buffered formaline.
Paraffin sections were cut at 3 and stained with Hematoxylin
and Eosin, Periodic acid-Schiff (PAS) and Masson's trichome.
Histometrical measurements were performed with the methods
previously reported [31. An index of sclerosis (IS) and relative
interstitial volume (IV) were calculated in each animal.
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Table 1. Intraglomerular leucocytesa
Calculated
CD4 T
Total CD8 cells"
Number Index of leucocytesb Monocytes" Ia cells" T cells" T cells" (OXl9t OX22
or rats sclerosis (OX1) (EDl) (OX6) (OX19) (OX8) OX8) cells"
Experiment 1
Before injection 5 0.07 0.02° 1.6 0.4c 1.0 0.1° 1.7 0.1C 0.5 0.1 0.3 0.1 0.2 0.2 1.2 0.2
AN + PS day 24 5 0.60 0.08 3.0 0.4 3.2 0.8 2.5 0.9 0.6 0.2 0.2 0.1 0.5 0.2 0.6 0.2
day 52 5 1.83 0.11 5.4 0.8 6.6 0.5 6.1 0.2 0.4 0.1 0.2 0.1 0.2 0.1 0.4 0.1
day 80 5 2.55 0.66" 4.9 0.6° 6.6 10" 4.5 0.7° 0.6 0.2 0.2 0.1 0.4 0.3 0.3 0.1
Saline day 80 5 0.08 0.01 2.3 0.4 2.1 0.5 2.5 0.6 0.4 0.1 0.2 0.1 0.2 0.1 0.3 0.1
Experiment 2
AN + PS, prednisolone 7 1.70 0.19 2.4 0.3 2.6 0.3 2.8 0.4 0.2 0.1 0 0.2 0.1 0.2 0.1
AN + PS, untreated 7 1.97 0.12 2.4 0.5 2.3 0.4 2.5 0.2 0.4 0.1 0.1 0.1 0.3 0.1 0.4 0.1
Saline, prednisolone 7 0.34 O.O9 1.2 0.2 1.1 0.2 1.2 0.4 0.4 0.2 0.1 0 0.2 0.1 0.1 0
Saline, untreated 7 0.09 0.03 1.0 0.1 0.8 0.3 0.5 0.1 0.4 0.1 0.1 0.1 0.3 0.1 0.2 0.1
a Data are mean SEM.b Per glomerular cross section
P < 0.01 vs. AN + PS (one-way ANOVA)
d P < 0.01
P < 0.05 vs. saline day 80 (Student's 1-test)
'P < 0.05 vs. saline prednisone-untreated (Student's 1-test)
Tissue localization of leucocytes
Portions of kidney were fixed in periodate-lysine-paraform-
aldehyde (PLP) for four hours, washed several times in phos-
phate buffered saline containing 7% sucrose, snap frozen and
stored at —80°C. Sections (6k) were labelled initially using
monoclonal antibody to rat leucocyte cell surface antigen and
sequentially using four layer technique of preoxidase and
antiperoxidase (PAP) as previously reported [9]. Monoclonal
markers used for analysis of leucocytes in the kidney were ED!
(for macrophages/monocytes) [101 and a series of MRC OX
antibodies, that is, OXI (total leucocytes), 0X6 (Ia positive
cells), 0X8 (CD8, suppressor/cytotoxic T cells), 0X19 (total T
cells), 0X22 (B cells, 60% W3/25 T cells + CD8) [1 1—14].
CD4 (helper) T cells in each rat were estimated by subtracting
the number of OX8 cells from that of OX19 cells.
Quantitation
Glomerular leucocytes. For each section including more than
10 glomeruli, the number of labelled cells was counted in each
glomerulus and expressed as the number of cells per glomerular
cross section.
Interstitial leucocytes. Labelled cells in the interstitium were
counted using an eye piece graticule to identify 25 microscopic
fields, each 0.04 mm2, and hence the total cell numbers were
expressed as cells per mm2. For each animal group, numbers
were expressed as the mean cells per square millimeter
standard error of mean (5EM).
Laboratory studies
Twenty-four hour urine samples were obtained from all
animals in metabolic cages for an initial control period and then
fortnightly during the course of the experiment. Blood was
obtained from the tail vein of each rat immediately following
urine collection. Urinary protein was measured by the standard
turbidimetric method with sulfosalicylic acid [15]. Creatinine
clearance (Car) was assessed from the results of urinary excre-
tion of creatinine (UcrV) and serum creatinine (Sr) and ex-
pressed as mi/mm/kg body weight.
Statistical analysis
All values are expressed as mean SEM. In experiment 1,
means between two groups and between more than three
groups were compared using unpaired Student's I-test and
one-way analysis of variances (ANOVA), respectively. The
time-course curves of cell populations in glomeruli were com-
pared using two-way ANOVA. In experiment 2, mean values
and the time-course curves between prednisolone-treated and
untreated groups was compared using unpaired Student's t-test
and two-way ANOVA, respectively. Difference between
groups or means was considered to be significant when P <
0.05.
Results
Experimental models
Experiment 1. The metabolic and histologic consequences of
progressive FGS were detailed in our previous report [31.
Briefly, rats showed marked and persistant proteinuria, hypoal-
buminemia and hypercholesterolemia during the evolution of
the disease. The glomerular changes were quite similar to
human FGS. On day 80, renal failure was indicated by the
marked decrease in C., and the histology mimicked the end
stage lesions in human FGS. The progression of the disease was
histometrically quantitated by the increase of index of glomer-
ular sclerosis (IS), and percentage increase in relative intersti-
tial volume (IV) (Tables 1 and 2).
Experiment 2. The treatment of prednisolone significantly
increased proteinuria in both the AN + PS group and saline
control group (Fig. 1), but prevented a significant deterioration
in creatinine clearance of AN + PS rats (Fig. 2). Histological
evaluation showed that expansion of interstitial volume in the
prednisolone-treated AN group was significantly less marked
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Table 2. Interstitial leucocyte?
Calculated
Relative Total CD4
Num- inter- leuco- Mono- CD8 T cellsb
ber of stitial cytesb cytesb T cells' T cells" (OXI9- OX22
rats volume (OXl) (EDl) (OXl9) (OX8) OX8) cellsb
Experiment 1
Before injection 5 15.2 0.9%" 259 63" 44 11" 17%C 76 15d 29%C 49 17 19%C 27 19" lO%C 31 10" 12%c
AN ÷ PS day 24 5 19.5 1.0 842 74 415 86 49 250 50 30 179 29 21 71 36 8 90 29 11
day 52 5 32.7 2.8 1852 207 776 129 42 682 60 37 349 84 19 333 109 18 277 61 15
day 80 5 42.9 2.7 1280 166C 439 96 34 718 139 56 73 lO 6 645 l34 50 330 I54 26
Saline day 80 5 11.9 0.9 207 32 22 3 11 106 30 51 40 6 19 67 26 32 8 2 4
Experiment 2
AN + PS, 7 25.0 3.7" 617 88 200 28" 32 175 14 28 172 31" 28 3 17g 0 80 19g 13
prednisolone
AN + PS, 7 38.8 4.7 1505 197 369 66 25 834 95 55 360 60 24 475 92 32 629 146 42
untreated
Saline, 7 13.6 0.6 141 20 45 8 32 75 17 53 60 10 43 16 9 11 10 4 7
prednisolone
Saline, untreated 7 15.3 0.8 97 15 33 8 34 48 10 49 38 9 39 17 6 18 10 2 10
a Mean SEM
b Cells/mm2
C Percentage of total leucocytes (defined by common leucocyte marker, OXI)
d P < 0.01 vs. AN + PS (one-way ANOVA)
P < 0.01
P< 0.05 vs. saline day 80 (Student's f-test)
P < 0.01
h P < 0.05 vs. AN +PS prednisolone-untreated (Student's t-test)
Fig. 1. Urinary total protein versus experimental days for groups in
which AN + PS or saline alone was administered, respectively.
Symbols are: (•) AN + PS, prednisolone-treated; (0) AN + PS,
prednisolone-untreated; (U) saline, prednisolone-treated; (Li) saline,
prednisolone-untreated. The time-course curves shows a significant
difference between prednisolone-treated and untreated groups (P <
0.01, two-way ANOVA). The mean values and standard error are
indicated by points and bars.
0 10 24 38 52 66 80
Experimental days
Fig. 2. Creatinine clearance versus experimental days for 4 animal
groups: (•) AN + PS, prednisolone-treated; (0), AN + PS, pred-
nisolone-untreated; (•) saline, prednisolone-treated; (0) saline, pred-
nisolone-untreated. The time-course curves show a significant differ-
ence between prednisolone-untreated AN + PS group and every other
group (P < 0.05, two-way ANOVA). The mean values and standard
error are indicated by points and bars.
Glomerular leucocyte infiltration
Experiment 1 (Fig. 4). The mean intraglomerular leucocyte
count, as defined by the common leucocyte antigen (OX1),
gradually and significantly increased from 1.6 0.4 (sEM) cells
per glomerular cross section before disease induction to 4.9
0.6 at day 80 (Fig. 5A). There was an increase in the number of
monocytes (Fig. SB) and in Ia cell count as identified by
AN + PS or saline
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than in the non-treated AN group (Table 2 and Fig. 3), although
prednisolone could not reduce the glomerular changes as indi-
cated by IS (Table 1).
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Fig. 3. Light micrographs of the kidney from AN + PS administered rats on day 80 in experimental 2: prednisolone-untreated (A) and treated (B).
Most of glomeruli show segmental sclerosis in both, but tubular atrophy and interstitial cell infiltration are markedly suppressed by
prednisolone-treatment (B). (Periodic acid-Schiff, x 100).
Experimental days
Fig. 4. Infiltrated ce/Is per g/omeru/ar cross section in AN + PS rats
versus experimental days for each leucocyte subset identified using
PAP technique by monoc/ona/ cell surface markers: (•) total leuko-
cytes (OX1); (0) monocytes (EDl); (A) Ia cells (OX6); (A) Tcel/s;(OX19); (U) suppressor T ce/Is (OX8); (LI) OX22 cells. The cell
numbers are significantly increased in OX1 , ED I * and OX6 (P <
0.01) but not in other cell groups (one-way ANOVA). The time course
curves are not significantly different between each two groups in OX l,
ED1 and OX6 (two-way ANOVA). The mean values and standard
error are indicated by points and bars.
monoclonal antibodies ED1 and 0X6, respectively. The accu-
mulation of monocytes was slightly greater than that of total
leucocytes or Ia cells, but the difference of the time course
curves was not significant when analyzed by two-way ANOVA.
There was no significant increase of T and B lymphocytes as
detected by 0X19, 0X8 and 0X22.
Experiment 2. There was no significant difference in cell
numbers between prednisolone treated and untreated AN + PS
groups when cells were identified by each monoclonal marker.
(Table 1).
Interstitial leucocyte infiltration
Experiment / (Fig. 6). Interstitial leucocyte infiltration was
present in the early stage of the disease when glomerular
sclerosis and interstitial expansion were mild. At day 24, each
cell component identified by monoclonal markers, OX1, ED1,
0X19, and 0X8, was significantly increased. Monocytes as
defined by ED1 were the predominant infiltrating cells repre-
senting about 50% of total leucocytes. However, late in the
disease process (day 80), infiltration of T cells identified by
0X19 was evident (Fig. 7B), and CD8 T cell infiltration
identified by 0X8 was less marked (Fig. 7C). Accordingly,
calculated CD4 were increased. OX22 cells comprising 26%
of the total leucocytes were intensely localized in parts of the
interstitium (Fig. 7D). T cells therefore play a prominant role in
the inflammatory infiltration, with progressively increasing
CD4±e and decreasing CD8±e cells.
80 Experiment 2 (Fig. 8). In AN + PS rats, all cell typesidentified by monoclonal markers, OX1, ED1, 0X19, 0X8 and
0X22, were significantly decreased in number at day 80 follow-
ing prednisolone treatment. In particular, the calculated
CD4"' cells were virtually eliminated in the prednisolone
treated animals.
Discussion
Most glomerulonephritides are believed to result from im-
mune mechanisms [16] and cellular immune mechanisms have
been incriminated in the intitiation and progression of the
disease [17—19]. Several previous studies of cellular immunity
have evaluated experimental models induced by immunological
procedures [20—22]. However, the FGS model in the current
study is induced by non-immunological methods using chemical
substances AN and PS [3]. Glomerular sclerosis followed the
epithelial injury and polyanion loss in the glomerulus induced
by co-administration of these agents [3].
There could be several factors which mediate the progressive
change in this FGS model following the initial proteinuria. It is
unlikely that the progressive glomerular-tubulointerstitial injury
is due to the toxic effect of chronic accumulation of AN-PS
because of the rapid turnover of the agents [23, 24]. The
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Fig. 5. Immunoperoxidase staining of a kidney from AN + PS rat on day 80 showing intraglomerular infiltration of total leukocytes (OX1) (A),
and monocytes (EDJ ) (B). OX! + cells are also seen in the periglomerular area but not EDI .
Fig. 6. Numbers (A) and percentage (B) of interstitial leucocyte sub-
sets in AN + PS rats versus experimental days for each subset
identf1ed using PAP technique by monoclonal surface markers. Sym-
bols are: (•) total leucocytes (OX1I; (0) monocytes (EDl); () T
cells (OXl9); (•) suppressor T cells (OX8); (LI) OX22 cells. The
cell numbers are significantly increased in OXl, OXl9, OX22 and
EDl (P <0.01) but not in OX8 (one-way ANOVA). The mean values
and standard error are indicated by points and bars.
proteinuria induced by AN disappears within two weeks when
one series of AN is administered [1, 2], and the effect of PS is
lost within a few hours [24]. Nevertheless, a delayed or pro-
longed toxic effect of these agents on the tubules, although
unlikely, cannot be excluded.
There is no evidence that AN nephrosis is directly related to
the immune system [1, 2]. It is unlikely that PS can trigger an
immune response because it is a low molecular protein which is
removed rapidly from the blood [231 and the kidney [24] and
does not remain "planted" in the glomerulus. Even so an
"immune" cellular infiltrate consisting of lymphocytes and
monocytes was a feature of this model, particularly in the
interstitium. Such an infiltrate could indicate that cellular im-
mune mechanisms may be involved, in "non-immune" initiated
renal disease as well as the immune-induced glomerulonephnt-
ides. It could be speculated that a common path for progression
of glomerulonephritis, independent of the initial aetiology, may
exist. Such a phenomenon could account for the ubiquitous
interstitial infiltration of leucocytes occurring in all types of
human glomerular diseases, apart from minimal change nephro-
sis [18].
In normal human and animal glomeruli, tissue culture and
immunohistologic techniques have demonstrated small num-
bers of macrophages or Ia positive cells, while T cells are rarely
seen [18—20]. The appearance in normal rat kidney prior to the
administration of AN and PS in our study confirmed these
previous observations. Following the repeated injection of AN
and PS as shown in experiment 1, leucocytes stained by OXI,
0X6 and ED1 gradually increased in number. However, there
was no significant difference in relative proportions of these
three cell populations. The number of T cell subsets within the
glomerulus stained by 0X8, 0X19 and 0X22 were not in-
creased at any stage of the disease. These results indicated that
the number of Ia macrophages independent of T cells were
increased in the glomerulus. Boyce et al [25] demonstrated that
ED1 cells in SD rats were macrophages and that their numbers
increased in glomeruli from rats with nephrotoxic nephritis, and
this was further confirmed in FGS rats using tissue culture [261.
The glomerular macrophage infiltration was minimal when the
glomerular sclerosis was comparatively mild, as at day 24 in
experiment 1. However, when glomerular sclerosis was more
severe later in the disease, macrophage infiltration was greater.
Another study on non-sclerotic AN nephrosis using monoclonal
antibodies failed to demonstrate macrophage accumulation in
glomeruli [27]. However, the biological changes were much
milder in this study, and no sclerotic changes developed. Thus
macrophage infiltration could have a role in the progression of
glomerular sclerosis although it may not be essential to its
initiation.
In previous reports, glomerular macrophage infiltration has
been demonstrated in proliferative glomerulonephritis and cres-
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Fig. 7. Immunoperoxidase staining of a kidney from AN + PS rat on day 80 showing interstitial infiltration of total leukocytes (OX] ) (A),
monocytes (EDI) (B), T cells (OX19 (C) and OX22 cells (D). Leucocytic infiltration including T cells as identified by OXl9 (C) and OX22
(D) are predominant.
centic glomerulonephritis but not in non-proliferative lesions
[18, 19]. However, Al-Shebeb, Fronlich and Magil [81 reported
that increased intraglomerular monocytic infiltration was de-
tected in experimental lipid-induced glomerulosclerosis. More-
over, several reports [36—39] have demonstrated that macro-
phages induce the activation of some coagulation factors,
including procoagulant acti,., .'hich triggers the extrinsic
pathway of coagulation leading to fibrin deposition. Since lipids
[2] and coagulation factors such as fibrin [39] may induce
irreversible sclerotic lesions in glomeruli, these results suggest
that glomerular macrophages may have an important role in the
progression of glomerular sclerosis whether the lesions are
initiated by immune mechanisms or not. On the other hand, T
cells are very rarely identified in non-proliferative glomerular
lesions such as FGS, in contrast with proliferative or crescentic
glomerulonephritis where they have been seen in some cases
[18, 19]. Therefore, glomerular macrophages in non-prolifera-
tive lesions may be stimulated by mechanisms other than T
cell-directed monocyte activation.
The number of infiltrating leucocytes within the interstitium
was increased throughout the evolution of the disease. Partic-
ularly, the infiltration of OXl9 and OX22 cells was marked.
However, care must be taken when extrapolating from in situ
phenotype as measured by surface markers to an assumed
function. This particularly pertains to T helper cells in the rat.
W3/25, which is commonly applied to the identification of
helper T cells, labels some macrophages in addition to helper T
cells [28], and also provides a fairly diffuse staining pattern in
the interstitium. Therefore an appreciation of the number of
helper T cells was provided by calculating the difference
between OX19 (total T cells) and OX8 (suppressor/cytotoxic
T cells). This interstitial helper T cell infiltration was further
confirmed by the large number of OX22 cells in the infiltrate
seen late in the disease, because 0X22 labels 60% of CD4 in
addition to OX8 T cells and B cells [14].
Macrophage accumulation in the interstitium was prominent
especially in the earlier stages of the disease. Interstitial infil-
tration of T cells and macrophages has been recognized in both
human glomerulonephritis [17, 18] and animal experimental
models [21, 271. However, the pattern of infiltrating T cell
subsets differs in each report. The result in our study was
similar to the pattern of the experimental interstitial nephritis
reported by Mampaso and Wilson [21] in that CD4le (helperT)
cells with the infiltration of monocytes were dominant at the
late stage with a decreased proportion of OX8±e (suppressor
T) cells. These findings suggest that a delayed type hypersen-
sitivity reaction (DTH), as characterized by the helper T cell
and macrophage infiltration, could be one factor in the intersti-
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tial injury seen later in the disease. In our FGS model, intersti-
tial volume changes developed in parallel with the glomerular
sclerotic changes [31. However, as demonstrated in this study,
interstitial cell infiltration was already observed on day 24 when
glomerular sclerosis was mild. Accordingly, interstitial changes
could develop independent of the glomerular lesions and this
aspect of the disease evolution requires further investigation to
define the mechanism [2].
In the steroid-treated rats, interstitial infiltration of T cells
and other macrophages was reduced together with interstitial
volume, in contrast to the lack of change in the glomerular
sclerotic lesions. This may suggest that the interstitial changes
have in part an immune component. Steroid therapy could not
influence the short-lived direct effects of AN and PS on glomer-
uli as there was a 12 day interval between the last injection of
AN + PS and the beginning of steroid therapy. Treatment with
prednisolone might not be expected to reduce glomerular
sclerotic changes because hypercoagulation [29, 30] and hyper-
filtration [31—33], both of which may be important factors in
progressive sclerosis [7, 331, may be induced by prednisolone
itself. However, the administration of prednisolone did reduce
the number of infiltrating leucocytes in the interstitium but not
in the glomeruli, and furthermore prevented deterioration in
creatinine clearance. Thus, in this study, the immunosuppres-
sive and anti-inflammatory effects of steroids ameliorated the
renal injury mediated by the infiltrating leucocytes. These
observations also agreed with previous studies [34, 35] showing
a correlation between interstitial changes, but not glomerular
changes, with glomerular filtration rate.
The current study makes it clear that the mode of cellular
infiltration is different in the glomerulus and the interstitium in
a type of non-immunologically initiated glomerulonephritis, and
could suggest that antigen-specific T lymphocyte-directed im-
mune mechanisms may contribute to disease progression in the
interstitium.
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